Hong Gyeong-su
Yeungnam University Hospital|Pulmonology
Daegu Nam-gu
Last updated
Tuberculosis/Non-tuberculous mycobacterial pulmonary diseaseInterstitial lung disease/Pulmonary fibrosisLung cancer/Pulmonary nodule
영남대의료원 임상교수로서 호흡기 중재적 시술에 특화된 전문성과 학술활동이 뒷받침하는 신뢰함
Medical opinions · Patient reviews0
No reviews yet.
If you've been treated by Hong Gyeong-su, be the first to leave a review.
Planning to see Hong Gyeong-su?
Save this doctor and find them again anytime on My page.
Hospital information
- Hospitals
- Yeungnam University Hospital
- Specialties
- More Pulmonology doctors
- Address
- 170 Hyeonchung-ro, Nam-gu, Daegu
- University
- 영남대학교 의과대학
- Appointments
- 053-620-4030Book by phone (053-620-4030)
Education and career
Education
- 2004.03 - 2011.02 영남대학교 의과대학 졸업
Career
- 2012.03 - 2016.02 영남대학교의료원 내과학 교실
- 2019.05 - 2021.02 영남대학교의료원 호흡기내과 전임의
- 2021.03 - 2023.02 영남대학교의료원 호흡기내과 임상교수
- 2023.03 - 현재 영남대학교의료원 호흡기내과 조교수
Academic societies
- 1. Hong KS, Ahn H, Lee KH, Chung JH, Shin KC, Jin HJ, Jang JG, Lee SS, Jang MH, Ahn JH. Radial probe endobronchial ultrasound using guide sheath-guided transbronchial lung biopsy in peripheral pulmonary lesions without fluoroscopy. Tuberc Respir Dis (Seoul). 2021 Jun 24.
- 2. Hong KS, Lee KH, Chung JH, Shin KC, Jin HJ, Jang JG, Ahn JH. Utility of Radial Probe Endobronchial Ultrasound Guided Transbronchial Lung Biopsy in Bronchus Sign Negative Peripheral Pulmonary Lesions. J Korean Med Sci. 2021 Jun 21;36(24).
- 3. Hong KS, Jang JG, Ahn JH, Radial probe endobronchial ultrasound-guided transbronchial lung biopsy for the diagnosis of cavitary peripheral pulmonary lesions. Thorac Cancer. 2021;1–8.
- 4. Hong KS, et al. Quantitative Assessment of Chest CT Patterns in COVID-19 and Bacterial Pneumonia Patients: a Deep Learning Perspective. J Korean Med Sci. 2021 Feb 1;36(5):e46
- 5. Hong KS, Ahn JH, Jang JG, Lee JH, Kim HN, Kim D, Lee W. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 Nov 17;5(1):267.
- 6. Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee W, Ahn JH. Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication. Infect Chemother. 2020 Sep;52(3):396-402.
- 7. Hong KS, Lee KH, Chung JH, Shin KC, Choi EY, Jin HJ, Jang JG, Lee W, Ahn JH. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Deive Study. Yonsei Med J. 2020 May;61(5):431-437.
- 8. Hong KS, Kim MC, Ahn JH. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011). Int J Chron Obstruct Pulmon Dis. 2020 May 7;15:1005-1014.
- 9. Hong KS, Ahn JH, Choi EY, Jin HJ, Shin KC, Chung JH, Lee KH. Microbiologic distribution and clinical features of nontuberculous mycobacteria in the tertiary hospital in Daegu. Yeungnam Univ J Med. 2015 Dec:32(2): 71-79.
- 10. Hong KS, Choi EY, Park DA, Park J. Safety and Efficacy of the Moderate Sedation During Flexible Bronchoscopic Procedure: A Systematic Review and -Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2015 Oct;94(40):e1459.
- 11. Lee YY, Park HH, Park W, Kim H, Jang JG, Hong KS, Lee JY, Seo HS, Na DH, Kim TH, Choy YB, Ahn JH, Lee W, Park CG. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials. 2020 Oct 23;267:120389.
- 12. Lee W, Ahn JH, Park HH, Kim HN, Kim H, Yoo Y, Shin H, Hong KS, Jang JG, Park CG, Choi EY, Bae JS, Seo YK. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020 Sep 3;5(1):186.
- 13. Kim HN, Park HH , Lim W , Hong KS, Ahn JH, Na DH, Kim IS, Jang JG, Bae JS, Lee W. Ferritin Nanocage‐d Methyltransferase SETD6 for COVID‐19 Therapy. Adv Funct Mater. 2020 Sep 30: 2006110.
- 14. Jang JG, Hur J, Choi EY, Hong KS, Lee W, Ahn JH. Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea. J Korean Med Sci. 2020 Jun 15;35(23):e209.
- 15. Chung SM, Lee YY, Ha E, Yoon JS, Won KC, Lee HW, Hur J, Hong KS, Jang JG, Jin HJ, Choi EY, Shin KC, Chung JH, Lee KH, Ahn JH, Moon JS. The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study. Diabetes b J. 2020 Jun;44(3):405-413.
- 16. Jang JG, Hur J, Hong KS, Lee W, Ahn JH. Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients. J Korean Med Sci. 2020 Jun 29;35(25):e234. doi: 10.3346/jkms.2020.35.e234. PMID: 32597046; PMCID: PMC7324266.
- 17. Kang M, Chikontwe P, Luna M, Hong KS, Jang KG, Park J, Shin KC, Ahn JH, Park SH. Quantitative Assessment of Chest CT Patterns in COVID-19 and Bacterial Pneumonia patients: A Deep Learning Perspective. medRxiv, 2020 Nov.:20231118
- 18. Chikontwe P, Luna M, Kang M, Hong KS, Ahn JH, Park SH. Dual Attention Multiple Instance Learning with Unsupervised Complementary Loss for COVID-19 Screening. medRxiv. 2020 Sep.:20194654
- 19. Jang JG, Chung JH, Hong KS, Ahn JH, Lee JY, Jo JH, Lee DW, Shin KC, Lee KH, Kim MJ, Lee JC, Lee JH, Lee JK. A case of solitary fibrous pleura tumor associated with severe hypoglycemia: doege-potter syndrome. Tuberc Respir Dis (Seoul). 2015 Apr;78(2):120-4.
- 20. Jang JG, Hong KS, Choi EY. A case of nonthrombotic pulmonary embolism after facial injection of hyaluronic Acid in an illegal cosmetic procedure. Tuberc Respir Dis (Seoul). 2014 Aug;77(2):90-3.
FAQ
- What conditions does Hong Gyeong-su treat?
- Hong Gyeong-su (Pulmonology, Yeungnam University Hospital) treats conditions such as Tuberculosis/Non-tuberculous mycobacterial pulmonary disease, Interstitial lung disease/Pulmonary fibrosis, Lung cancer/Pulmonary nodule.
- Where does Hong Gyeong-su see patients?
- In Pulmonology at Yeungnam University Hospital. The hospital address is 170 Hyeonchung-ro, Nam-gu, Daegu.
- What is Hong Gyeong-su's specialty?
- Specialty: Pulmonology.
Is any information wrong?
Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.